Panacea Biotec has received a Letter of Award (LoA) from UNICEF for supply of 115 million doses of its bivalent oral polio vaccine (bOPV) worth around $14.95 million (around Rs 127 crore) in CY2025.
The supply of bOPV to UNICEF is for its requirements in countries in Africa / Asia region as per the orders as may be received from time to time.
Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1915.55 |
| Dr. Reddys Labs. | 1368.75 |
| Cipla | 1471.25 |
| Zydus Lifesciences | 1148.90 |
| Lupin | 2490.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: